4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-25-045295
Chief Scientific Officer sold 2,631 shares at $6.60 ($17,365)
- Chief Scientific Officer acquired 2,631 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…